Bleeding control improves after switching to emicizumab: Real-world experience of 177 children in the PedNet registry.

Konrad van der Zwet Marloes de KovelJayashree MotwaniChris van GeetBeatrice NolanHeidi GlosliCarmen Escuriola EttingshausenChristoph KönigsTami Livnat Kathelijn Fischernull null

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2024)

This study showed improved bleeding control compared to previous treatment and a favourable safety profile during emicizumab therapy in paediatric haemophilia A patients.

Keyphrases

end stage renal disease
atrial fibrillation
ejection fraction
newly diagnosed
chronic kidney disease
emergency department
young adults
prognostic factors
peritoneal dialysis
patient reported outcomes
mesenchymal stem cells
combination therapy
replacement therapy
smoking cessation
patient reported